Frequency Therapeutics Company Leadership

KRRO Stock   12.72  0.15  1.19%   
About 75% of Frequency Therapeutics' corporate insiders are selling. The analysis of the overall insider sentiment regarding Frequency Therapeutics suggests that many insiders are alarmed. Frequency Therapeutics employs about 87 people. The company is managed by 21 executives with a total tenure of roughly 203 years, averaging almost 9.0 years of service per executive, having 4.14 employees per reported executive.

Insider Sentiment 25

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2024-11-11Vineet AgarwalDisposed 800 @ 70View
2024-10-17Vineet AgarwalDisposed 10216 @ 78.26View
2024-04-22Venture Opportunity Fund AtlasAcquired 17857 @ 56View
2023-11-22David L LucchinoDisposed 1156 @ 37.69View
Monitoring Frequency Therapeutics' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.

Frequency Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.2916) % which means that it has lost $0.2916 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6346) %, meaning that it created substantial loss on money invested by shareholders. Frequency Therapeutics' management efficiency ratios could be used to measure how well Frequency Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 10th of February 2026, Return On Tangible Assets is likely to drop to -0.35. In addition to that, Return On Capital Employed is likely to drop to -0.41. At this time, Frequency Therapeutics' Non Current Assets Total are very stable compared to the past year. As of the 10th of February 2026, Non Currrent Assets Other is likely to grow to about 7.5 M, while Total Assets are likely to drop about 173.2 M.
As of the 10th of February 2026, Common Stock Shares Outstanding is likely to grow to about 10.8 MThe majority of Frequency Therapeutics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Frequency Therapeutics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Frequency Therapeutics. Please pay attention to any change in the institutional holdings of Frequency Therapeutics as this could imply that something significant has changed or is about to change at the company.
 
Shares in Circulation  
First Issued
2019-09-30
Previous Quarter
9.4 M
Current Value
9.4 M
Avarage Shares Outstanding
4.3 M
Quarterly Volatility
3.8 M
 
Covid
 
Interest Hikes
Some institutional investors establish a significant position in stocks such as Frequency Therapeutics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Frequency Therapeutics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Frequency Therapeutics Workforce Comparison

Frequency Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,097. Frequency Therapeutics holds roughly 87.0 in number of employees claiming about 8% of equities under Health Care industry.

Frequency Therapeutics Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Frequency Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Frequency Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Frequency Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Frequency Therapeutics Notable Stakeholders

A Frequency Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Frequency Therapeutics often face trade-offs trying to please all of them. Frequency Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Frequency Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Andrew FraleyCoFounder AdvisorProfile
Joshua RosenthalCoFounder AdvisorProfile
Josh RosenthalCoFounder AdvisorProfile
Ram MBAPresident, CEOProfile
Nessan BerminghamCoFounder ChairmanProfile
MBA MDCoFounder DirectorProfile
Marco PassiniVP biologyProfile
Shelby JDSenior CounselProfile
Loic VincentChief OfficerProfile
Vineet MBAChief OfficerProfile
Ravi RamadasVice DevelopmentProfile
Oliver DolanInterim OfficerProfile
Steven CollettiChief OfficerProfile
Todd MBAChief OfficerProfile
Venkat KrishnamurthySenior PlatformProfile
Stephanie EngelsSenior CultureProfile
Gaozhong ZhuManufacturing ChemistryProfile
Todd ChappellChief OfficerProfile
PharmD JDSenior CounselProfile
Kemi MDChief OfficerProfile
Olukemi MDAdvisorProfile
String symbol = request.getParameter("s");

About Frequency Therapeutics Management Performance

The success or failure of an entity such as Frequency Therapeutics often depends on how effective the management is. Frequency Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Frequency management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Frequency management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.33)(0.35)
Return On Capital Employed(0.39)(0.41)
Return On Assets(0.33)(0.35)
Return On Equity(0.60)(0.57)

Frequency Therapeutics Workforce Analysis

Traditionally, organizations such as Frequency Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Frequency Therapeutics within its industry.

Frequency Therapeutics Manpower Efficiency

Return on Frequency Therapeutics Manpower

Revenue Per Employee26.1K
Revenue Per Executive108.1K
Net Loss Per Employee960.7K
Net Loss Per Executive4M
Working Capital Per Employee1.3M
Working Capital Per Executive5.6M
When determining whether Frequency Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Frequency Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Frequency Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Frequency Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Will Biotechnology sector continue expanding? Could Frequency diversify its offerings? Factors like these will boost the valuation of Frequency Therapeutics. Expected growth trajectory for Frequency significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Frequency Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(9.42)
Revenue Per Share
0.786
Return On Assets
(0.29)
Return On Equity
(0.63)
Understanding Frequency Therapeutics requires distinguishing between market price and book value, where the latter reflects Frequency's accounting equity. The concept of intrinsic value - what Frequency Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Frequency Therapeutics' price substantially above or below its fundamental value.
Understanding that Frequency Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Frequency Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Frequency Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.